/Sponsor / Executive Profile

Eduardo Bravo Fernandez de Araoz

Executive

Aggregate Capital Deployment Matrix

Professional Biography

Eduardo Bravo Fernandez de Araoz has served as EBAC’s Chief Executive Officer since EBAC’s inception.

Total Capital Deployed

$100,000,000

Active / Searching Capital:
-

Transaction Volume

2 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

0.0%

Professional Network Intelligence

Frequent Associates

Top Sectors

  • Biopharmaceuticals1 Deals
  • Biopharmaceutical1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
OCS
Oculis Holding AG
closed
-
$10.00
1/1Apr 2023Done-Biopharmaceuticals
Oculis
EBAC
European Biotech Acquisition Corp.
closed
100.0M
$10.00
1/3Feb 2021Done-BiopharmaceuticalCredit Suisse Securities (USA) LLC